+59%

est. 2Y upside i

Series A

Helping farmers maximize crop yield

Rank

#1416

Sector

AgTech

Est. Liquidity

~4Y

Data Quality

Data: Low

Instacrops is a speculative equity bet: the enterprise customer roster and claimed 100% growth are compelling signals, but the company has not raised capital since April 2021, revenue data is 3+ years old, and there is no disclosed current valuation or profitability figure.

Last updated: May 14, 2026

Bull (28%)+200%

Instacrops converts enterprise pilots with Bayer, Monsanto, Dole, and Nestlé into 7-figure recurring contracts and expands beyond Latin America, raising a Series B at ~$110-130M post-money within 18-24 months from an estimated ~$40M baseline today. Common equity triples driven by revenue scaling toward $20M+ ARR and a re-rating to global AgTech SaaS multiples on 70% gross margins.

Base (42%)+65%

The company grows to $12-15M ARR by 2028 and raises a Series B at $55-70M, delivering ~1.6x paper gains from an estimated $40M current baseline, though secondary liquidity remains unavailable. LatAm market concentration and a 5-year gap since the April 2021 Series A cap the multiple expansion; employees see modest unrealized gains contingent on a future exit.

Bear (30%)-80%

After five years without new capital, the company is unable to raise a Series B on acceptable terms, accepts a distressed sale or shuts down, and $5.95M in liquidation preferences ahead of common equity leaves employees with near-zero recovery. Revenue data being 3+ years stale and only 19 employees heighten the risk that disclosed metrics no longer reflect reality.

Est. time to liquidity~4.0 years

Preference Stack Risk

high

Funding Intensity

17%

$5.95M in total liquidation preferences sits ahead of common equity against an estimated current valuation of ~$30-40M, implying ~15-20% of enterprise value is absorbed before common holders see a dollar.

Dilution Risk

high

Series A with no subsequent raise in 5 years means a Series B is overdue and will likely impose 20-35% additional dilution on current common holders at minimum.

Secondary Liquidity

none

No secondary market or tender program exists for a 19-person Chilean AgTech at Series A stage; equity is fully illiquid until a formal M&A or IPO event.

Questions to Ask at the Interview

Strategic questions based on Instacrops's data — designed to show you've done your homework.

  • 1

    “What is the company's current ARR as of today, monthly cash burn, and how many months of runway remain without additional fundraising?”

  • 2

    “How are the contracts with Bayer, Monsanto, Dole, and Nestlé structured — multi-year SaaS subscriptions, usage-based pilots, or one-time integrations — and what is the net revenue retention rate?”

  • 3

    “Can you walk me through the cap table, including all liquidation preference tiers and participation rights, and what is the board's target timeline and mechanism for a liquidity event?”

Community

Valuation Sentiment

Our model estimates +59% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.